Erik Jedenius

1.2k total citations · 1 hit paper
23 papers, 841 citations indexed

About

Erik Jedenius is a scholar working on Psychiatry and Mental health, Philosophy and Geriatrics and Gerontology. According to data from OpenAlex, Erik Jedenius has authored 23 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 5 papers in Philosophy and 4 papers in Geriatrics and Gerontology. Recurrent topics in Erik Jedenius's work include Schizophrenia research and treatment (17 papers), Dementia and Cognitive Impairment Research (7 papers) and Mental Health and Psychiatry (5 papers). Erik Jedenius is often cited by papers focused on Schizophrenia research and treatment (17 papers), Dementia and Cognitive Impairment Research (7 papers) and Mental Health and Psychiatry (5 papers). Erik Jedenius collaborates with scholars based in Sweden, Belgium and Finland. Erik Jedenius's co-authors include Heidi Taipale, Jari Tiihonen, Dana Enkusson, Amy Levál, Juha Mehtälä, Fabian Hoti, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Jan Sermon and Maila Majak and has published in prestigious journals such as Scientific Reports, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Erik Jedenius

22 papers receiving 823 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

2017 438 citations Jari Tiihonen, Ellenor Mittendorfer‐Rutz et al. JAMA Psychiatry profile →

Peers

Countries citing papers authored by Erik Jedenius

Since Specialization

Citations

This map shows the geographic impact of Erik Jedenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jedenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jedenius more than expected).

Fields of papers citing papers by Erik Jedenius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jedenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jedenius. The network helps show where Erik Jedenius may publish in the future.

Co-authorship network of co-authors of Erik Jedenius

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jedenius. A scholar is included among the top collaborators of Erik Jedenius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jedenius. Erik Jedenius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring 2020 ·Scientific Reports ·Heidi Taipale, Syed Rahman, Antti Tanskanen, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon, Jari Tiihonen, Ellenor Mittendorfer‐Rutz	3
2	Patients’ perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate – a qualitative interview study 2020 ·Nordic Journal of Psychiatry ·Marit By Rise, (unknown), (unknown), Berith Hedberg, Katja Stahl, (unknown), Erik Jedenius, (unknown)	7
3	Scandinavian user perspectives on three-monthly administrations of antipsychotic medication 2019 ·European Psychiatry ·(unknown), Berith Hedberg, (unknown), (unknown), Katja Stahl, (unknown), Erik Jedenius, (unknown), Marit By Rise	1
4	Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT) 2019 ·Schizophrenia Research ·Jeanette Westman, Jonas Eberhard, Fiona Gaughran, Lennart Lundin, (unknown), Gunnar Edman, Sven V. Eriksson, Erik Jedenius, (unknown), (unknown), Daniel A. Abrams, Kathryn Greenwood, Shubuladè Smith, Khalida Ismail, Robin Murray, Urban Ösby	8
5	“I live, I don't work, but I live a very normal life”—A qualitative interview study of Scandinavian user experiences of schizophrenia, antipsychotic medication, and personal recovery processes 2019 ·Perspectives In Psychiatric Care ·(unknown), (unknown), (unknown), Berith Hedberg, Katja Stahl, (unknown), Erik Jedenius, Marit By Rise	15
6	Burden for Parents of Patients With Schizophrenia—A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls 2018 ·Schizophrenia Bulletin ·Ellenor Mittendorfer‐Rutz, Syed Rahman, Antti Tanskanen, Maila Majak, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon, Heidi Taipale, Jari Tiihonen	28
7	Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia 2017 ·Schizophrenia Research ·Heidi Taipale, Ellenor Mittendorfer‐Rutz, Kristina Alexanderson, Maila Majak, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon, Antti Tanskanen, Jari Tiihonen	178
8	Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29,823 patients 2017 ·European Neuropsychopharmacology ·Jari Tiihonen, Ellenor Mittendorfer‐Rutz, Maila Majak, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon, Antti Tanskanen, Heidi Taipale	1
9	Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia breakdown → 2017 ·JAMA Psychiatry ·Jari Tiihonen, Ellenor Mittendorfer‐Rutz, Maila Majak, Juha Mehtälä, Fabian Hoti, Erik Jedenius, Dana Enkusson, Amy Levál, Jan Sermon, Antti Tanskanen, Heidi Taipale	438
10	Diabetes and glucose disturbances in patients with psychosis in Sweden 2015 ·BMJ Open Diabetes Research & Care ·Eric Olsson, Jeanette Westman, (unknown), Sven V. Eriksson, Gunnar Edman, Robert Bodén, Erik Jedenius, Johan Reutfors, (unknown), Agneta Hilding, Martin Schalling, Claes‐Göran Östenson, Urban Ösby	7
11	Comparing estimated cost per patient for dementia care: Two municipalities and Swedish national population data 2015 ·Clinical Nursing Studies ·Erik Jedenius, Anders Wimo, (unknown), Johan Fastbom, Bengt Winblad, Ulrika Winblad, Nancy C. Andreasen	1
12	Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application 2013 ·Alzheimer s Research & Therapy ·Carina Wattmo, Erik Jedenius, Kaj Blennow, Åsa K. Wallin	18
13	Galantamine Versus Risperidone Treatment of Neuropsychiatric Symptoms in Patients with Probable Dementia: An Open Randomized Trial 2013 ·American Journal of Geriatric Psychiatry ·Yvonne Freund‐Levi, Erik Jedenius, (unknown), (unknown), Lars‐Olof Wahlund, Maria Eriksdotter	21
14	The economic impact of galantamine vs placebo: An analysis based on functional capacity in a Swedish cohort study 2012 ·Journal of Medical Economics ·Anders Wimo, (unknown), Barbara Schäuble, Erik Jedenius	2
15	Dementia management programme in a community setting and the use of psychotropic drugs in the elderly population 2011 ·Scandinavian Journal of Primary Health Care ·Erik Jedenius, Kristina Johnell, Johan Fastbom, (unknown), Bengt Winblad, Niels Andreasen	15
16	Galantamine and behavior in Alzheimer disease: analysis of four trials 2011 ·Acta Neurologica Scandinavica ·(unknown), (unknown), B. Van Baelen, Marina Rossato Adami, (unknown), (unknown), Erik Jedenius, Barbara Schäuble	38
17	A symptom Self-rating Scale for Schizophrenia (4S): Psychometric properties, reliability and validity 2009 ·Nordic Journal of Psychiatry ·Eva Lindström, Erik Jedenius, Sten Levander	15
18	The cost of diagnosing dementia in a community setting 2009 ·International Journal of Geriatric Psychiatry ·Erik Jedenius, Anders Wimo, (unknown), Linus Jönsson, Niels Andreasen	16
19	A Swedish programme for dementia diagnostics in primary healthcare 2008 ·Scandinavian Journal of Primary Health Care ·Erik Jedenius, Anders Wimo, (unknown), Niels Andreasen	18
20	A checklist for assessment of treatment in schizophrenic syndromes: Interscale validity and interrater reliability 1996 ·European Neuropsychopharmacology ·Eva Lindström, Lisa Ekselius, Erik Jedenius, Anna‐Lena Almqvist, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact